# Dose-dependent anxiolytic and antidepressant-like effects of chronic oxytocin in corticosterone-induced female mouse model of anxiety and depression

**Authors:** Masayoshi Mori, Misaki Tamura, Norihiro Sumi, Hiroyoshi Harada, Yusuke Murata

PMC · DOI: 10.1016/j.bbrep.2026.102510 · Biochemistry and Biophysics Reports · 2026-02-18

## TL;DR

Chronic oxytocin treatment in female mice showed dose-dependent effects on reducing anxiety and depression caused by corticosterone.

## Contribution

The study reveals a non-linear dose-dependent effect of oxytocin on emotional behaviors in a female mouse model of anxiety and depression.

## Key findings

- A 0.1 mg/kg dose of oxytocin blocked corticosterone-induced anxiety and depression-like behaviors.
- A 1 mg/kg dose of oxytocin increased plasma oxytocin levels but did not affect emotional behaviors.
- Oxytocin regulated emotional behaviors in a non-linear dose-dependent manner in female mice.

## Abstract

Oxytocin (OXT) has therapeutic effects on psychiatric disorders, such as anxiety and depression, in both animals and humans; however, an increasing number of OXT treatment studies have reported conflicting results. Although the effects of OXT on emotion regulation vary depending on factors such as sex and dosage, the dose-dependent effects of chronic OXT administration remain unclear, particularly in women. In this study, we aimed to assess the dose-dependent effects of chronic OXT administration on emotional behavior in female mice with corticosterone (CORT)-induced anxiety and depression. A total of 58 female C57BL/6J mice received daily co-administration of OXT (0.1 or 1 mg/kg, intraperitoneal) and/or CORT (40 mg/kg, subcutaneous) for 4 weeks, and their anxiety- (open field and elevated plus maze tests) and depression-like behaviors (forced swimming and tail suspension tests) were evaluated. A 0.1 mg/kg dose of OXT blocked the CORT-induced increase in anxiety-like behavior (open field test) and depression-like behavior (forced swimming test), whereas the 1 mg/kg dose did not. Similarly, a dose-dependent effect of OXT was observed in the elevated plus maze and tail suspension tests. Furthermore, the 1 mg/kg dose of OXT significantly increased plasma OXT levels. These findings suggest that a certain level of OXT signaling activity is needed to exert anxiolytic and antidepressant-like effects, which may lead to a non-linear dose-dependent effect of OXT in a female mouse model of CORT-induced anxiety and depression. Targeting dose-dependent OXT signaling is a potential therapeutic strategy for women with psychiatric disorders.

•Simultaneous oxytocin (0.1 mg/kg) blocked the aversive effects of corticosterone.•Simultaneous oxytocin (1 mg/kg) exerted any effects on emotional behaviors.•Simultaneous oxytocin (1 mg/kg) elevated peripheral oxytocin levels.•Oxytocin regulated emotion in a non-linear dose-dependent manner in female mice.

Simultaneous oxytocin (0.1 mg/kg) blocked the aversive effects of corticosterone.

Simultaneous oxytocin (1 mg/kg) exerted any effects on emotional behaviors.

Simultaneous oxytocin (1 mg/kg) elevated peripheral oxytocin levels.

Oxytocin regulated emotion in a non-linear dose-dependent manner in female mice.

## Linked entities

- **Proteins:** OXT (oxytocin/neurophysin I prepropeptide)
- **Chemicals:** corticosterone (PubChem CID 5753)
- **Diseases:** anxiety (MONDO:0005618), depression (MONDO:0002050)

## Full-text entities

- **Genes:** OXT (oxytocin/neurophysin I prepropeptide) [NCBI Gene 5020] {aka OT, OT-NPI, OXT-NPI}, Gpr34 (G protein-coupled receptor 34) [NCBI Gene 23890] {aka Lypsr1}, Oxt (oxytocin) [NCBI Gene 18429] {aka OT, Oxy}, Creb1 (cAMP responsive element binding protein 1) [NCBI Gene 12912] {aka 2310001E10Rik, 3526402H21Rik, Creb, Creb-1}, Bdnf (brain derived neurotrophic factor) [NCBI Gene 12064], Oxt (oxytocin/neurophysin I prepropeptide) [NCBI Gene 25504]
- **Diseases:** autism (MESH:D001321), anxiety (MESH:D001007), behavioral impairments (MESH:D001523), Depression (MESH:D003866), anxiety disorders (MESH:D001008), neurodevelopmental disorders (MESH:D002658)
- **Chemicals:** OXT (MESH:D010121), C2505 (-), saline (MESH:D012965), CORT (MESH:D003345), dexamethasone (MESH:D003907), water (MESH:D014867), steroid hormone (MESH:D013256), DMSO (MESH:D004121), Tween 80 (MESH:D011136), heparin (MESH:D006493)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12933838/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12933838/full.md

## References

71 references — full list in the complete paper: https://tomesphere.com/paper/PMC12933838/full.md

---
Source: https://tomesphere.com/paper/PMC12933838